Cellectis - ADR

NASDAQ:CLLS  
1.58
-0.07 (-4.24%)
3:11:35 PM EDT: $1.58 0.00 (0.04%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)109.08M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$11.23 Million
Adjusted EPS-$0.20
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Cellectis - ADR Stock, NASDAQ:CLLS

8, rue de la Croix Jarry, Paris, Ile-de-France 75013
France
Phone: +33.1.81.69.16.00
Number of Employees: 222
http://www.cellectis.com

Description

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and Andr�© Choulika on February 20, 1999 and is headquartered in Paris, France.